Alnair Therapeutics

Alnair is a preclinical stage, platform precision oncology company focused on new methods to treat difficult-to-treat cancers. We developed a first-in-class drug delivery technology that leverages the unique features of cancer metabolism to enhance targeting and penetration of drugs directly to cancer cells, and to improve treatment outcomes for patients.